Moran Wealth Management »

Catalyst Pharmaceutical Partners shares owned by Moran Wealth Management

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Moran Wealth Management from 13F filings

Historical chart of Moran Wealth Management investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Moran Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Moran Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $516k 26k 19.70
2025-06-30 $726k 33k 21.70
2025-03-31 $757k 31k 24.25
2024-12-31 $210k 10k 20.87

More positions owned by Moran Wealth Management

Broadcom (AVGO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Parker-Hannifin Corporation (PH)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Trane Technologies SHS (TT)
Cadence Design Systems (CDNS)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Garmin SHS (GRMN)
Howmet Aerospace (HWM)
Williams-Sonoma (WSM)
Ameriprise Financial (AMP)
Progressive Corporation (PGR)
NetApp (NTAP)
Linde SHS (LIN)

View all positions for Moran Wealth Management

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Renaissance Technologies
Fundsmith
Morgan Stanley
Geode Capital Management
American Century Companies
Dimensional Fund Advisors
Royce & Associates
Millennium Management
Charles Schwab Investment Management
Arrowstreet Capital, Limited Partnership
Robeco Investment Management

View all funds holding Catalyst Pharmaceutical Partners